Global Medical, European center team up for cancer treatment

GLOBAL Medical Technologies Manila has formed a partnership with the Europe-based Research Genetic Cancer Center (RGCC) to provide personalized cancer treatment in the Philippines.

“Our partnership with RGCC is now in place,” Mitch Genato, group chief executive officer of Global Medical Technologies, said in a press

RGCC Medical Director and CEO Ioannis Papasotiriou said - lating tumor cells (CTCs).

“Cancer disease should be con according to Papasotiriou.

He noted that medical doctors that a treatment for one patient is the same treatment for another.

“Something is wrong with our algorithm... All humans are not identical,” Papasotiriou said.

- based on assumptions,” he added.

- count, a screening test that gives information on the presence and concentration of circulating tumor cells. It also has the Oncotrace that shows the presence of CTCs, their

RGCC also uses Oncotrail that control on old cancers.

“We do not care if we need to deal with a single individual with - pasotiriou said.

he added.

The RGCC Group was estab and distributors to provide worldwide service. It selects collaborators that are well-established.

According to its website, RGCC is “is a pioneering, innovative or medical genetics and, in particular, and chemo-resistance testing and in Research and Development within the pharmaceutical indus

Its headquarters is in Switzerland, and RGCC’s brand-new, state-of-the art laboratories are in Northern Greece that are equipped with the - vanced and innovative equipment.